Communication
RSC Advances
a good lead, based on its high binding energy and high anti- streptomycin for antibacterial and ascorbic acid for antioxidant
bacterial activity, which is further supported by experimental activity, and hence ethylenophane 1a may be a potential lead
results.
molecule for the synthesis of drugs with both antibacterial and
antioxidant activities. Synthesis of similar types of ethyl-
enophanes and antibacterial and antioxidant studies are
underway.
Antioxidant activity
The DPPH assay is an easy, rapid and sensitive method to screen
the antioxidant activity of the given test compounds.31 In the
present study the antioxidant capacity of the ethylenophanes 1–
4 were analyzed by a DPPH assay. All ve ethylenophanes
showed signicant scavenging of the free radical generated by
DPPH. The free radical scavenging property of all the ethyl-
enophanes was tested from the lowest concentration of 10 mg
mLꢁ1 up to the highest concentration of 50 mg mLꢁ1. The
scavenging activity increases with increasing concentration of
the ethylenophanes. The free radical scavenging properties of
all ethylenoindolophanes are given in Fig. 3. The ethylenophane
1a showed excellent free radical scavenging activity at all
concentrations with an IC50 value of 28 mg mLꢁ1 and it is more
effective than the other four ethylenophanes. Ascorbic acid
(vitamin C) was used as a standard to measure the free radical
scavenging by DPPH assay. The IC50 values of all compounds
and the standard are given in Fig. 4.
Acknowledgements
The authors thank CSIR, New Delhi, India, for nancial assis-
tance, DST-FIST for providing NMR specialities to the depart-
ment and SAIF, IIT Madras for mass spectral data. NV thanks
DST, CSIR, New Delhi for a fellowship.
Notes and references
1 F. V. Nussbaum, Angew. Chem., Int. Ed., 2003, 42, 3068.
2 J. Yu, T. Wang, X. Liu, J. Deschamps, J. F. Anderson, X. Liao
and J. M. Cook, J. Org. Chem., 2003, 68, 7565.
3 G. J. Bodwell, J. Li and D. O. Miller, Tetrahedron, 1999, 55,
12939.
4 B. Ortner, R. Waibel and P. Gmeinwe, Angew. Chem., Int. Ed.,
2001, 40, 1283.
5 E. Von Angerer and J. Strohmeier, J. Med. Chem., 1987, 30,
131.
6 E. J. Glamkowski, J. M. Fortunato, T. C. Spaulding,
J. C. Wilker and D. B. Ellis, J. Med. Chem., 1985, 28, 66.
7 P. C. Unangst, M. E. Carethers, K. Webster, G. M. Janik and
L. J. Robichaud, J. Med. Chem., 1984, 27, 1629.
8 H. Sano, T. Noguchi, A. Miyajima, Y. Hashimoto and
H. Miyachi, Bioorg. Med. Chem. Lett., 2006, 16, 3068.
9 J. Perregaard, J. Arnt, K. P. Hyttel and C. Sanchez, J. Med.
Chem., 1992, 35, 1092.
In conclusion, we have synthesized biologically active indole
based ethylenophanes 1, 1a, 2, 3 and 4 from various dibromides
by direct N-arylation methodology followed by Vilsmeier for-
mylation and McMurry coupling for the rst time. Among the
ethylenophanes, ethylenophane 1a exhibited antibacterial and
antioxidant properties similar to that of standard drugs such as
10 D. C. Cole, J. W. Ellingboe, W. J. Lennox, H. Mazandarani,
D. L. Smith, J. R. Stock, G. M. Zhang, P. Zhou and
L. E. Schechter, Bioorg. Med. Chem. Lett., 2005, 15, 379.
11 Q. Li, T. M. Li, K. W. Woods, W. Z. Gu, J. Cohen, V. S. Stoll,
T. Galicia, C. Hutchins, D. Frost, S. H. Rosenberg and
H. L. Sham, Bioorg. Med. Chem. Lett., 2005, 15, 2918.
12 H. Xu, W. Q. Liu, L. L. Fan, Y. Chen, L. M. Yang, L. Lv and
Y. T. Zheng, Chem. Pharm. Bull., 2008, 56, 720.
´
´
13 A. Longeon, B. R. Copp, E. Quevrain, M. Roue, B. Kientz,
T. Cresteil, S. Petek, C. Debitus and M. L. Bourguet-
Kondracki, Mar. Drugs, 2011, 9, 879.
Fig.
3 In vitro free radical scavenging activity of the ethyl-
enoindolophanes 1–4.
14 Y. Sugiyama, Y. Ito, M. Suzuku and A. Hirota, J. Nat. Prod.,
2009, 72, 2069.
15 A. F. Pozharskii, B. K. Martsokha and A. M. Simonov, Zh.
Obshch. Khim., 1963, 33, 1005.
16 H. Xu, Mini-Rev. Org. Chem., 2009, 6, 367.
17 (a) T. Yamato, C. Hideshima, Y. Nagano and M. Tashiro, J.
Chem. Res., 1996, 45, 266; (b) H. W. Losensky,
¨
H. Selthanan, A. Ehlen, F. Vogtle and J. Bargon, Angew.
Chem., 1988, 100, 1225; (c) H. L. Larkins and
A. D. Hamilton, Tetrahedron Lett., 1986, 27, 2721; (d)
T. K. Vinod and H. Hart, Tetrahedron Lett., 1988, 29, 885;
(e) H. C. Kang, A. W. Hanson, B. Eaton and V. Boekelheide,
J. Am. Chem. Soc., 1985, 107, 1979; (f) M. Chastrette and
Fig. 4 IC50 values for the ethylenoindolophanes 1–4 and ascorbic
acid (vit. C).
This journal is © The Royal Society of Chemistry 2014
RSC Adv., 2014, 4, 21190–21194 | 21193